SCHEMBL7990799

SCHEMBL7990799

COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(c1ccc2c(c1)OCO2)C(O)c1ccccc1-c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
HCRTR1 O43613 1/20 0.49
MMP2 P08253 1/20 0.46
MMP9 P14780 1/20 0.46
MMP8 P22894 1/20 0.46
IL1RN P18510 3/20 0.45
ERAP2 Q6P179 2/20 0.45
MAPT P10636 1/20 0.45
NPBWR1 P48145 1/20 0.45
MCHR1 Q99705 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7976634 0.92 MAPK1 (0.53) MAPK1SMN1; SMN2
SCHEMBL7987295 0.91 MAPK1 (0.55) MAPK1SMN1; SMN2KMT2AMEN1HCRTR1
SCHEMBL7976134 0.90 SMN1; SMN2 (0.58) MAPK1SMN1; SMN2KMT2AMEN1HCRTR1
SCHEMBL7990128 0.86 MAPK1 (0.57) MAPK1SMN1; SMN2KMT2AMEN1HCRTR1
SCHEMBL7990269 0.86 MAPK1 (0.53) MAPK1SMN1; SMN2KMT2AMEN1HCRTR1
SCHEMBL7986343 0.86 SMN1; SMN2 (0.56) MAPK1SMN1; SMN2KMT2AMEN1HCRTR1
SCHEMBL7988090 0.85 SMN1; SMN2 (0.53) MAPK1SMN1; SMN2KMT2AMEN1HCRTR1
SCHEMBL7993252 0.85 SMN1; SMN2 (0.56) MAPK1SMN1; SMN2KMT2AMEN1HCRTR1
SCHEMBL7986588 0.85 SMN1; SMN2 (0.56) MAPK1SMN1; SMN2KMT2AMEN1HCRTR1
SCHEMBL7990434 0.85 SMN1; SMN2 (0.52) MAPK1SMN1; SMN2KMT2AMEN1HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207686-B1 FOR THERAPY OF HYPERTENSION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-03-27 US disclosed